Joanne S. Eglovitch

Nov 12, 2024 | friendsofcancerresearch.org | Joanne S. Eglovitch

Robert Califf, commissioner of the US Food and Drug Administration (FDA), said he is “disappointed” in the outcome of the presidential election and warned of potential changes coming to the agency under a second Trump administration.

Sep 9, 2024 | friendsofcancerresearch.org | Joanne S. Eglovitch

Pragmatic clinical trials (PCTs) offer a promising alternative to explanatory trials, according to a recent commentary published in the ESMO Real World Data and Digital Oncology. Such trials feature simplified study protocols and data collection methods and enable a wider patient selection pool, which the authors believe can enhance clinical research.

May 10, 2024 | friendsofcancerresearch.org | Joanne S. Eglovitch

Peter Marks, director of the US Food and Drug Administration’s (FDA) Center for Biologics Evaluation and Research (CBER), said his center is doing a “pretty good job” of filling positions under the current Prescription Drug User Fee Act (PDUFA VII) agreement at a meeting sponsored by the Friends for Cancer Research (FOCR) and Parker Institute for Cancer Immunotherapy (PICI) in Washington, DC on Monday.

Mar 9, 2023 | breathinglabs.com | Joanne S. Eglovitch

Feb 24, 2023 | friendsofcancerresearch.org | Michael Mezher |Joanne S. Eglovitch